Suchergebnisse - Elizaveta S. Leshchiner
- Treffer 1 - 10 von 10
-
1
Direct activation of full-length proapoptotic BAK von Elizaveta S. Leshchiner, Craig R. Braun, Geoffrey Bird, Loren D. Walensky
Veröffentlicht 2013Artigo -
2
-
3
-
4
-
5
-
6
Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver von Akin Akinc, Michael S. Goldberg, June Qin, J. Robert Dorkin, Christina Gamba‐Vitalo, Martin A. Maier, K. N. Jayaprakash, Muthusamy Jayaraman, Kallanthottathil G. Rajeev, Muthiah Manoharan, Victor Koteliansky, Ingo Röhl, Elizaveta S. Leshchiner, Róbert Langer, Daniel G. Anderson
Veröffentlicht 2009Artigo -
7
Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease von Elizaveta S. Leshchiner, Jason S. Rush, Michael A. Durney, Zhifang Cao, Vlado Dančík, Benjamin Chittick, Huixian Wu, Adam Petrone, Joshua A. Bittker, Andrew J. Phillips, José R. Perez, Alykhan F. Shamji, Virendar K. Kaushik, Mark J. Daly, Daniel B. Graham, Stuart L. Schreiber, Ramnik J. Xavier
Veröffentlicht 2017Artigo -
8
Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation von Zhifang Cao, Kara L. Conway, Robert J. W. Heath, Jason S. Rush, Elizaveta S. Leshchiner, Zaida G. Ramirez‐Ortiz, Natalia B. Nedelsky, Hailiang Huang, Aylwin Ng, Agnès Gardet, Shih‐Chin Cheng, Alykhan F. Shamji, John D. Rioux, Cisca Wijmenga, Mihai G. Netea, Terry K. Means, Mark J. Daly, Ramnik J. Xavier
Veröffentlicht 2015Artigo -
9
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis von Yilong Zou, Michael J. Palte, Amy Deik, Haoxin Li, John K. Eaton, Wenyu Wang, Yuen‐Yi Tseng, Rebecca Deasy, Maria Kost‐Alimova, Vlado Dančík, Elizaveta S. Leshchiner, Vasanthi S. Viswanathan, Sabina Signoretti, Toni K. Choueiri, Jesse S. Boehm, Bridget K. Wagner, John G. Doench, Clary B. Clish, Paul A. Clemons, Stuart L. Schreiber
Veröffentlicht 2019Artigo -
10
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics von Akin Akinc, Andreas Zumbuehl, Michael S. Goldberg, Elizaveta S. Leshchiner, Valentina Busini, Naushad Hossain, Sergio Bacallado, David N. Nguyen, Jason Fuller, Rene Alvarez, Anna Borodovsky, Todd Borland, Rainer Constien, Antonin de Fougerolles, J. Robert Dorkin, K. N. Jayaprakash, Muthusamy Jayaraman, Matthias John, Victor Koteliansky, Muthiah Manoharan, Lubomir V. Nechev, June Qin, Timothy Racie, Denitza Raitcheva, Kallanthottathil G. Rajeev, Dinah W.Y. Sah, Jürgen Soutschek, Ivanka Toudjarska, Hans‐Peter Vornlocher, Tracy Zimmermann, Róbert Langer, Daniel G. Anderson
Veröffentlicht 2008Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Biology
Gene
Biochemistry
Cell biology
Chemistry
Apoptosis
Enzyme
Genetics
Programmed cell death
RNA
RNA interference
Bcl-2-associated X protein
Biotechnology
Cancer research
Caspase 3
Cell cycle
Computational biology
Drug delivery
Gene silencing
Immunology
In vitro
In vivo
Mitochondrion
Mutant
Organic chemistry
Small interfering RNA
Activator (genetics)
Bcl-2 family
Bioinformatics
Biophysics